{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:52:24Z","timestamp":1787496744748,"version":"build-2736575974"},"reference-count":149,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS) with a complex and not fully understood etiopathological background involving inflammatory and neurodegenerative processes. CHI3L1 has been implicated in pathological conditions such as inflammation, injury, and neurodegeneration, and is likely to play a role in the physiological development of the CNS. CHI3L1 is primarily produced by CNS macrophages, microglia, and activated astrocytes. The CHI3L1 expression pattern in MS lesions might support the important role of astrocytes in modulating inflammatory processes in this disease. The potential applications of CHI3L1 as a biomarker in MS are multifactorial. The measurement of CHI3L1 in body fluids might find its role in the early diagnosis of MS. In further stages, the monitoring of CHI3L1 levels might provide information on disease severity and progression, enabling a better adjustment of therapeutic strategies. Importantly, CHI3L1 might potentially serve as a marker of ongoing glial activation, reflecting the dynamic response of the CNS cells to the inflammatory processes in MS. Although preliminary findings have been promising, further research is needed to validate the utility of CHI3L1 measurements in the diagnosis and prediction of the progression of MS. Additionally, comparisons with other biomarkers might be useful in clinical practice.<\/jats:p>","DOI":"10.3390\/cells13242086","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T10:54:02Z","timestamp":1734432842000},"page":"2086","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["CHI3L1 in Multiple Sclerosis\u2014From Bench to Clinic"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6566-421X","authenticated-orcid":false,"given":"Izabela","family":"Jatczak-Pawlik","sequence":"first","affiliation":[{"name":"Department of Neurology, Medical University of Lodz, Kosciuszki Street 4, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jurewicz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Lodz, Kosciuszki Street 4, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7804-9926","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Domowicz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Lodz, Kosciuszki Street 4, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-8669","authenticated-orcid":false,"given":"Alicja","family":"Ewiak-Paszy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Lodz, Kosciuszki Street 4, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2582-1708","authenticated-orcid":false,"given":"Mariusz","family":"Stasio\u0142ek","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Lodz, Kosciuszki Street 4, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2174\/187152712801661266","article-title":"Multiple Sclerosis: Risk Factors and Their Interactions","volume":"11","author":"Disanto","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/WCO.0b013e3283533a7e","article-title":"Vitamin D and Multiple Sclerosis: Epidemiology, Immunology, and Genetics","volume":"25","author":"Simon","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e37297","DOI":"10.1097\/MD.0000000000037297","article-title":"Review of Multiple Sclerosis: Epidemiology, Etiology, Pathophysiology, and Treatment","volume":"103","author":"Haki","year":"2024","journal-title":"Medicine"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Huss, A., Otto, M., Senel, M., Ludolph, A.C., Abdelhak, A., and Tumani, H. (2020). A Score Based on NfL and Glial Markers May Differentiate Between Relapsing\u2013Remitting and Progressive MS Course. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.00608"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ncl.2017.08.006","article-title":"Progressive Forms of Multiple Sclerosis: Distinct Entity or Age-Dependent Phenomena","volume":"36","author":"Zeydan","year":"2018","journal-title":"Neurol. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/WCO.0000000000000206","article-title":"Classification, Diagnosis, and Differential Diagnosis of Multiple Sclerosis","volume":"28","year":"2015","journal-title":"Curr. Opin. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of Multiple Sclerosis: 2017 Revisions of the McDonald Criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"105496","DOI":"10.1016\/j.msard.2024.105496","article-title":"Cervical Lymph Node Diameter Reflects Disease Progression in Multiple Sclerosis","volume":"84","author":"Tuulasvaara","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","article-title":"HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"102647","DOI":"10.1016\/j.autrev.2020.102647","article-title":"The Role of TH17 Cells in Multiple Sclerosis: Therapeutic Implications","volume":"19","author":"Moser","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The Expanding Universe of T-Cell Subsets: Th1, Th2 and More","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol. Today"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/imr.12169","article-title":"Regulatory T Cells in Autoimmune Neuroinflammation","volume":"259","author":"Kleinewietfeld","year":"2014","journal-title":"Immunol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.25927","article-title":"The Role of B Cells in Multiple Sclerosis and Related Disorders","volume":"89","author":"Comi","year":"2021","journal-title":"Ann. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14712598.2019.1568407","article-title":"B Cell Depletion in the Treatment of Multiple Sclerosis","volume":"19","author":"Myhr","year":"2019","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5383099","DOI":"10.1155\/2024\/5383099","article-title":"The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis","volume":"2024","author":"Sarkar","year":"2024","journal-title":"J. Immunol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/brain\/awl043","article-title":"Impaired Maturation and Altered Regulatory Function of Plasmacytoid Dendritic Cells in Multiple Sclerosis","volume":"129","author":"Stasiolek","year":"2006","journal-title":"Brain J. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"van Langelaar, J., Rijvers, L., Smolders, J., and van Luijn, M.M. (2020). B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00760"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Woodberry, T., Bouffler, S.E., Wilson, A.S., Buckland, R.L., and Br\u00fcstle, A. (2018). The Emerging Role of Neutrophil Granulocytes in Multiple Sclerosis. J. Clin. Med., 7.","DOI":"10.3390\/jcm7120511"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rossi, B., Constantin, G., and Zenaro, E. (2020). The Emerging Role of Neutrophils in Neurodegeneration. Immunobiology, 225.","DOI":"10.1016\/j.imbio.2019.10.014"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.autrev.2017.01.013","article-title":"Neutrophil Perversion in Demyelinating Autoimmune Diseases: Mechanisms to Medicine","volume":"16","author":"Casserly","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e1583","DOI":"10.1002\/wsbm.1583","article-title":"Neurodegeneration in Multiple Sclerosis","volume":"15","author":"Mey","year":"2023","journal-title":"WIREs Mech. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/1352458516672017","article-title":"Personalised Medicine for Multiple Sclerosis Care","volume":"23","author":"Gafson","year":"2017","journal-title":"Mult. Scler."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/jnnp-2012-304094","article-title":"Brain Atrophy and Lesion Load Predict Long Term Disability in Multiple Sclerosis","volume":"84","author":"Popescu","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.0000000000006583","article-title":"Misdiagnosis of Multiple Sclerosis","volume":"92","author":"Solomon","year":"2019","journal-title":"Neurology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s00415-022-11488-y","article-title":"Present and Future of the Diagnostic Work-up of Multiple Sclerosis: The Imaging Perspective","volume":"270","author":"Filippi","year":"2023","journal-title":"J. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e13323","DOI":"10.1016\/j.heliyon.2023.e13323","article-title":"Biomarkers: Promising and Valuable Tools towards Diagnosis, Prognosis and Treatment of Covid-19 and Other Diseases","volume":"9","author":"Bodaghi","year":"2023","journal-title":"Heliyon"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Graner, M., Pointon, T., Manton, S., Green, M., Dennison, K., Davis, M., Braiotta, G., Craft, J., Edwards, T., and Polonsky, B. (2020). Oligoclonal IgG Antibodies in Multiple Sclerosis Target Patient-Specific Peptides. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0228883"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jamaneurol.2024.0017","article-title":"Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis","volume":"81","author":"Cross","year":"2024","journal-title":"JAMA Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e200052","DOI":"10.1212\/NXI.0000000000200052","article-title":"Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients with Progressive Multiple Sclerosis","volume":"10","author":"Barro","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e1164","DOI":"10.1212\/NXI.0000000000001164","article-title":"Role of Chitinase 3\u2013like 1 as a Biomarker in Multiple Sclerosis","volume":"9","author":"Floro","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/1352458510392619","article-title":"Chitinase Effects on Immune Cell Response in Neuromyelitis Optica and Multiple Sclerosis","volume":"17","author":"Correale","year":"2011","journal-title":"Mult. Scler."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1590\/0004-282x-anp-2020-0326","article-title":"Serum YKL-40 Levels in Patients with Multiple Sclerosis","volume":"79","author":"Ozdemir","year":"2021","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1534\/genetics.107.075846","article-title":"Evolution of Mammalian Chitinase(-Like) Members of Family 18 Glycosyl Hydrolases","volume":"177","author":"Bussink","year":"2007","journal-title":"Genetics"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"25803","DOI":"10.1016\/S0021-9258(19)74461-5","article-title":"Human Cartilage Gp-39, a Major Secretory Product of Articular Chondrocytes and Synovial Cells, Is a Mammalian Member of a Chitinase Protein Family","volume":"268","author":"Hakala","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/sj.bjc.6690238","article-title":"Serum YKL-40 and Colorectal Cancer","volume":"79","author":"Cintin","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1432-1327.1998.2510504.x","article-title":"Chitotriosidase, a Chitinase, and the 39-kDa Human Cartilage Glycoprotein, a Chitin-Binding Lectin, Are Homologues of Family 18 Glycosyl Hydrolases Secreted by Human Macrophages","volume":"251","author":"Renkema","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-023-01131-9","article-title":"Significance of Chitinase-3-like Protein 1 in the Pathogenesis of Inflammatory Diseases and Cancer","volume":"56","author":"Yu","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1750-3639.2011.00550.x","article-title":"Astrocyte and Macrophage Regulation of YKL-40 Expression and Cellular Response in Neuroinflammation","volume":"22","author":"Bissel","year":"2012","journal-title":"Brain Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.coi.2008.10.002","article-title":"Chitin Regulation of Immune Responses: An Old Molecule with New Roles","volume":"20","author":"Lee","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.biotechadv.2013.09.012","article-title":"From Bacteria to Human: A Journey into the World of Chitinases","volume":"31","author":"Adrangi","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5578\/tt.3773","article-title":"Chitinases and Lung Diseases","volume":"61","author":"Duru","year":"2013","journal-title":"Tuberk. Toraks"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-020-00303-7","article-title":"Chitinase-3 like-Protein-1 Function and Its Role in Diseases","volume":"5","author":"Zhao","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-2094-7-34","article-title":"In Vivo CHI3L1 (YKL-40) Expression in Astrocytes in Acute and Chronic Neurological Diseases","volume":"7","author":"Wang","year":"2010","journal-title":"J. Neuroinflamm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e972","DOI":"10.1212\/NXI.0000000000000972","article-title":"Potential Role of CHI3L1+ Astrocytes in Progression in MS","volume":"8","author":"Lassmann","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2174\/1871527315666160803153459","article-title":"Every Cloud Has a Silver Lining: Proneurogenic Effects of A\u03b2 Oligomers and HMGB-1 via Activation of the RAGE-NF-\u03baB Axis","volume":"16","author":"Bortolotto","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCRESAHA.109.195834","article-title":"S100B Interaction with the Receptor for Advanced Glycation End Products (RAGE): A Novel Receptor-Mediated Mechanism for Myocyte Apoptosis Postinfarction","volume":"106","author":"Tsoporis","year":"2010","journal-title":"Circ. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.bbadis.2014.06.017","article-title":"Involvement of the Nuclear High Mobility Group B1 Peptides Released from Injured Hepatocytes in Murine Hepatic Fibrogenesis","volume":"1842","author":"Kao","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3858\/emm.2011.43.9.059","article-title":"Inhibitory Effect of Receptor for Advanced Glycation End Products (RAGE) on the TGF-\u03b2-Induced Alveolar Epithelial to Mesenchymal Transition","volume":"43","author":"Song","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000381464","article-title":"HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-\u03b2 via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells","volume":"41","author":"Cheng","year":"2015","journal-title":"Am. J. Nephrol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Guarneri, F., Custurone, P., Papaianni, V., and Gangemi, S. (2021). Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases. Antioxidants, 10.","DOI":"10.3390\/antiox10010082"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"36535","DOI":"10.18632\/oncotarget.5440","article-title":"Chitinase 3-like 1 Induces Survival and Proliferation of Intestinal Epithelial Cells during Chronic Inflammation and Colitis-Associated Cancer by Regulating S100A9","volume":"6","author":"Low","year":"2015","journal-title":"Oncotarget"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"eadg8148","DOI":"10.1126\/sciadv.adg8148","article-title":"CHI3L1 Signaling Impairs Hippocampal Neurogenesis and Cognitive Function in Autoimmune-Mediated Neuroinflammation","volume":"9","author":"Jiang","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"114226","DOI":"10.1016\/j.celrep.2024.114226","article-title":"Astrocyte-Derived CHI3L1 Signaling Impairs Neurogenesis and Cognition in the Demyelinated Hippocampus","volume":"43","author":"Song","year":"2024","journal-title":"Cell Rep."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Wu, S., Tan, Y., Li, F., Han, Y., Zhang, S., and Lin, X. (2024). CD44: A Cancer Stem Cell Marker and Therapeutic Target in Leukemia Treatment. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1354992"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13046-018-0876-2","article-title":"Chitinase 3-like 1-CD44 Interaction Promotes Metastasis and Epithelial-to-Mesenchymal Transition through \u03b2-Catenin\/Erk\/Akt Signaling in Gastric Cancer","volume":"37","author":"Geng","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1158\/0008-5472.CAN-21-3629","article-title":"Chi3l1 Is a Modulator of Glioma Stem Cell States and a Therapeutic Target in Glioblastoma","volume":"83","author":"Karambizi","year":"2023","journal-title":"Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Fujisawa, T., Joshi, B.H., Takahashi, S., Takasaki, Y., Suzuki, A., Ito, K., Ochiai, K., Tomishima, K., Ishii, S., and Puri, R.K. (2021). IL-13R\u03b12 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer. Diagnostics, 11.","DOI":"10.3390\/diagnostics11071140"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1165\/rcmb.2019-0446OC","article-title":"N-Glycosylation Regulates Chitinase 3-like-1 and IL-13 Ligand Binding to IL-13 Receptor A2","volume":"63","author":"He","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1172\/JCI79792","article-title":"Chitinase 3\u2013like\u20131 and Its Receptors in Hermansky-Pudlak Syndrome\u2013Associated Lung Disease","volume":"125","author":"Zhou","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.stem.2018.07.009","article-title":"GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease","volume":"23","author":"Li","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_63","first-page":"PA535","article-title":"Relationship between CRTH2 mRNA Expression in Peripheral Blood and IgE and Eosinophil Levels in Adult Patients with Asthma","volume":"54","author":"Moreno","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#","article-title":"CRTH2 Is the Most Reliable Marker for the Detection of Circulating Human Type 2 Th and Type 2 T Cytotoxic Cells in Health and Disease","volume":"30","author":"Cosmi","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G.P., Bellotti, C., Salehi, L.B., and Ricci, A. (2018). Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020379"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.4049\/jimmunol.1701442","article-title":"Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease","volume":"200","author":"Zhou","year":"2018","journal-title":"J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"D\u2019Addio, F., Assi, E., Maestroni, A., Rossi, G., Usuelli, V., Petrazzuolo, A., Nardini, M., Loretelli, C., Ben Nasr, M., and Fiorina, P. (2024). TMEM219 Regulates the Transcription Factor Expression and Proliferation of Beta Cells. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1306127"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"12752","DOI":"10.1038\/ncomms12752","article-title":"IL-13R\u03b12 Uses TMEM219 in Chitinase 3-like-1-Induced Signalling and Effector Responses","volume":"7","author":"Lee","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.1212\/NXI.0000000000000921","article-title":"Chitinases and Chitinase-like Proteins as Biomarkers in Neurologic Disorders","volume":"8","author":"Pinteac","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/brain\/awv017","article-title":"Chitinase 3-like 1: Prognostic Biomarker in Clinically Isolated Syndromes","volume":"138","author":"Canto","year":"2015","journal-title":"Brain"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1177\/1352458514561906","article-title":"Chitinase 3-like Proteins as Diagnostic and Prognostic Biomarkers of Multiple Sclerosis","volume":"21","author":"Hinsinger","year":"2015","journal-title":"Mult. Scler."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jneuroim.2016.01.013","article-title":"YKL-40 Is a CSF Biomarker of Intrathecal Inflammation in Secondary Progressive Multiple Sclerosis","volume":"292","author":"Burman","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2016.08.004","article-title":"Glial and Neuronal Markers in Cerebrospinal Fluid in Different Types of Multiple Sclerosis","volume":"299","author":"Olsson","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/jnc.13881","article-title":"Cerebrospinal Fluid Biomarkers as a Measure of Disease Activity and Treatment Efficacy in Relapsing-Remitting Multiple Sclerosis","volume":"141","author":"Novakova","year":"2017","journal-title":"J. Neurochem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1352458516639384","article-title":"Cerebrospinal Fluid Biomarkers of Inflammation and Degeneration as Measures of Fingolimod Efficacy in Multiple Sclerosis","volume":"23","author":"Novakova","year":"2017","journal-title":"Mult. Scler."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2014.02.004","article-title":"CSF Levels of YKL-40 Are Increased in MS and Replaces with Immunosuppressive Treatment","volume":"269","author":"Axelsson","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Ponath, G., Park, C., and Pitt, D. (2018). The Role of Astrocytes in Multiple Sclerosis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00217"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awq035","article-title":"Cerebrospinal Fluid Chitinase 3-like 1 Levels Are Associated with Conversion to Multiple Sclerosis","volume":"133","author":"Comabella","year":"2010","journal-title":"Brain J. Neurol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2353\/ajpath.2008.080045","article-title":"YKL-40, a Marker of Simian Immunodeficiency Virus Encephalitis, Modulates the Biological Activity of Basic Fibroblast Growth Factor","volume":"173","author":"Bissel","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"24438","DOI":"10.1074\/jbc.M211980200","article-title":"Proteomic Analysis of Astrocytic Secretion in the Mouse. Comparison with the Cerebrospinal Fluid Proteome","volume":"278","author":"Adjali","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1096\/fj.10-161851","article-title":"Role of CCR5 and Its Ligands in the Control of Vascular Inflammation and Leukocyte Recruitment Required for Acute Excitotoxic Seizure Induction and Neural Damage","volume":"25","author":"Louboutin","year":"2011","journal-title":"FASEB J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.33418","article-title":"The CD14(Bright) CD16+ Monocyte Subset Is Expanded in Rheumatoid Arthritis and Promotes Expansion of the Th17 Cell Population","volume":"64","author":"Rossol","year":"2012","journal-title":"Arthritis Rheumatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.4049\/jimmunol.1400874","article-title":"RelB\/P50 Complexes Regulate Cytokine-Induced YKL-40 Expression","volume":"194","author":"Bhardwaj","year":"2015","journal-title":"J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/1352458511433063","article-title":"Chitinase 3-like 1 Plasma Levels Are Increased in Patients with Progressive Forms of Multiple Sclerosis","volume":"18","author":"Reverter","year":"2012","journal-title":"Mult. Scler."},{"key":"ref_85","first-page":"351","article-title":"YKL-40, a Mammalian Member of the Chitinase Family, Is a Matrix Protein of Specific Granules in Human Neutrophils","volume":"110","author":"Volck","year":"1998","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/geno.1997.4778","article-title":"Molecular Characterization of the Gene for Human Cartilage Gp-39 (CHI3L1), a Member of the Chitinase Protein Family and Marker for Late Stages of Macrophage Differentiation","volume":"43","author":"Rehli","year":"1997","journal-title":"Genomics"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Jafari, B., Elias, J.A., and Mohsenin, V. (2014). Increased Plasma YKL-40\/Chitinase-3-Like-Protein-1 Is Associated with Endothelial Dysfunction in Obstructive Sleep Apnea. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098629"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"13076","DOI":"10.1074\/jbc.270.22.13076","article-title":"Identification of a 38-kDa Heparin-Binding Glycoprotein (Gp38k) in Differentiating Vascular Smooth Muscle Cells as a Member of a Group of Proteins Associated with Tissue Remodeling","volume":"270","author":"Shackelton","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s10753-018-0806-7","article-title":"Neutrophils as a Potential Source of Chitinase-3-like Protein 1 in Cystic Fibrosis","volume":"41","author":"Coriati","year":"2018","journal-title":"Inflammation"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"\u017burawska-P\u0142aksej, E., \u0141ugowska, A., Hetma\u0144czyk, K., Knapik-Kordecka, M., and Piwowar, A. (2015). Neutrophils as a Source of Chitinases and Chitinase-Like Proteins in Type 2 Diabetes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0141730"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1086\/315050","article-title":"YKL-40, a Matrix Protein of Specific Granules in Neutrophils, Is Elevated in Serum of Patients with Community-Acquired Pneumonia Requiring Hospitalization","volume":"180","author":"Nordenbaek","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/1352458518767043","article-title":"Cerebrospinal Fluid Chitinase-3-like Protein 1 Level Is Not an Independent Predictive Factor for the Risk of Clinical Conversion in Radiologically Isolated Syndrome","volume":"25","author":"Thouvenot","year":"2019","journal-title":"Mult. Scler."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/1352458514549397","article-title":"Glial and Neuronal Markers in Cerebrospinal Fluid Predict Progression in Multiple Sclerosis","volume":"21","author":"Olsson","year":"2015","journal-title":"Mult. Scler."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Ku\u0161nierov\u00e1, P., Zeman, D., Hrad\u00edlek, P., Zapletalov\u00e1, O., and Stejskal, D. (2020). Determination of Chitinase 3-like 1 in Cerebrospinal Fluid in Multiple Sclerosis and Other Neurological Diseases. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0233519"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/brain\/awy021","article-title":"Neurofilament Light Chain and Oligoclonal Bands Are Prognostic Biomarkers in Radiologically Isolated Syndrome","volume":"141","author":"Villar","year":"2018","journal-title":"Brain"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1007\/s10072-023-06764-2","article-title":"Chitinase-3-like 1-Protein in CSF: A Novel Biomarker for Progression in Patients with Multiple Sclerosis","volume":"44","author":"Talaat","year":"2023","journal-title":"Neurol. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12974-018-1249-7","article-title":"Neurofilament Levels, Disease Activity and Brain Volume during Follow-up in Multiple Sclerosis","volume":"15","author":"Tisell","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1021\/pr3012107","article-title":"Effects of Natalizumab Treatment on the Cerebrospinal Fluid Proteome of Multiple Sclerosis Patients","volume":"12","author":"Stoop","year":"2013","journal-title":"J. Proteome Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/jnc.15824","article-title":"Astrocytic Chitinase-3-like Protein 1 in Neurological Diseases: Potential Roles and Future Perspectives","volume":"165","author":"Li","year":"2023","journal-title":"J. Neurochem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/alz.12612","article-title":"Potential Role of Chitinase-3-like Protein 1 (CHI3L1\/YKL-40) in Neurodegeneration and Alzheimer\u2019s Disease","volume":"19","author":"Connolly","year":"2023","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00702-022-02470-z","article-title":"Serum NfL and CHI3L1 for ALS and Parkinsonian Disorders in the Process of Diagnosis","volume":"129","author":"Haji","year":"2022","journal-title":"J. Neural Transm."},{"key":"ref_102","first-page":"4423","article-title":"High Levels of Serum HER-2\/Neu and YKL-40 Independently Reflect Aggressiveness of Metastatic Breast Cancer","volume":"9","author":"Jensen","year":"2003","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.urolonc.2007.07.020","article-title":"Serum YKL-40 Levels and Chitotriosidase Activity as Potential Biomarkers in Primary Prostate Cancer and Benign Prostatic Hyperplasia","volume":"26","author":"Kucur","year":"2008","journal-title":"Urol. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Gil-Perotin, S., Castillo-Villalba, J., Cubas-Nu\u00f1ez, L., Gasque, R., Hervas, D., Gomez-Mateu, J., Alcala, C., Perez-Miralles, F., Gascon, F., and Dominguez, J.A. (2019). Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.01008"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1021\/acs.jproteome.2c00460","article-title":"Multifaceted Analysis of Cerebrospinal Fluid and Serum from Progressive Multiple Sclerosis Patients: Potential Role of Vitamin C and Metal Ion Imbalance in the Divergence of Primary Progressive Multiple Sclerosis and Secondary Progressive Multiple Sclerosis","volume":"22","author":"Pomary","year":"2023","journal-title":"J. Proteome Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/acn3.427","article-title":"Pharmacodynamic Effects of Daclizumab in the Intrathecal Compartment","volume":"4","author":"Komori","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12035-022-03060-6","article-title":"CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis","volume":"60","author":"Lucchini","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1177\/1352458518794308","article-title":"Prognostic Value of Cerebrospinal Fluid Neurofilament Light Chain and Chitinase-3-like-1 in Newly Diagnosed Patients with Multiple Sclerosis","volume":"25","author":"Sellebjerg","year":"2019","journal-title":"Mult. Scler."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1212\/NXI.0000000000000422","article-title":"Neurofilament Light Chain Predicts Disease Activity in Relapsing-Remitting MS","volume":"5","author":"Varhaug","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.msard.2019.07.030","article-title":"The Predictive Value of CSF Multiple Assay in Multiple Sclerosis: A Single Center Experience","volume":"35","author":"Fino","year":"2019","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Lereim, R.R., Nytrova, P., Guldbrandsen, A., Havrdova, E.K., Myhr, K.-M., Barsnes, H., and Berven, F.S. (2024). Natalizumab Promotes Anti-Inflammatory and Repair Effects in Multiple Sclerosis. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0300914"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2016.12.006","article-title":"Chitinase 3-like 1 Is Associated with the Response to Interferon-Beta Treatment in Multiple Sclerosis","volume":"303","author":"Villar","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.autrev.2007.02.003","article-title":"Glatiramer Acetate: Mechanisms of Action in Multiple Sclerosis","volume":"6","author":"Schrempf","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ene.13274","article-title":"Neurofilament Light Chain in Cerebrospinal Fluid and Prediction of Disease Activity in Clinically Isolated Syndrome and Relapsing\u2013Remitting Multiple Sclerosis","volume":"24","author":"Tisell","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1177\/1352458517726592","article-title":"Defining Active Progressive Multiple Sclerosis","volume":"23","author":"Sellebjerg","year":"2017","journal-title":"Mult. Scler."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Masvekar, R., Phillips, J., Komori, M., Wu, T., and Bielekova, B. (2021). Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory Activity. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.649876"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e906","DOI":"10.1212\/NXI.0000000000000906","article-title":"Chitinase 3-like 1 and Neurofilament Light Chain in CSF and CNS Atrophy in MS","volume":"8","author":"Schneider","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Abdelhak, A., Hottenrott, T., Morenas-Rodr\u00edguez, E., Su\u00e1rez-Calvet, M., Zettl, U.K., Haass, C., Meuth, S.G., Rauer, S., Otto, M., and Tumani, H. (2019). Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.00280"},{"key":"ref_119","first-page":"229","article-title":"Increased Serum Levels of Some Inflammatory Markers in Patients with Multiple Sclerosis","volume":"105","author":"Uysal","year":"2014","journal-title":"Minerva Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/acn3.52187","article-title":"Serum Glial Fibrillary Acidic Protein Predicts Disease Progression in Multiple Sclerosis","volume":"11","author":"Madill","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_121","first-page":"410","article-title":"Serum Biomarker Levels Predict Disability Progression in Patients with Primary Progressive Multiple Sclerosis","volume":"95","author":"Fissolo","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1038\/s41467-023-42682-9","article-title":"Proteomics Reveal Biomarkers for Diagnosis, Disease Activity and Long-Term Disability Outcomes in Multiple Sclerosis","volume":"14","author":"Hojjati","year":"2023","journal-title":"Nat Commun"},{"key":"ref_123","first-page":"3933","article-title":"Correlation of Selected Serum Protein Levels with the Degree of Disability and NEDA-3 Status in Multiple Sclerosis Phenotypes","volume":"26","author":"Urban","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Magliozzi, R., Mazziotti, V., Montibeller, L., Pisani, A.I., Marastoni, D., Tamanti, A., Rossi, S., Crescenzo, F., and Calabrese, M. (2020). Cerebrospinal Fluid IgM Levels in Association With Inflammatory Pathways in Multiple Sclerosis Patients. Front. Cell. Neurosci., 14.","DOI":"10.3389\/fncel.2020.569827"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/ene.13687","article-title":"Cognitive Impairment in Early Stages of Multiple Sclerosis Is Associated with High Cerebrospinal Fluid Levels of Chitinase 3-like 1 and Neurofilament Light Chain","volume":"25","author":"Quintana","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"\u015awiderek-Matysiak, M., Oset, M., Domowicz, M., Galazka, G., Namieci\u0144ska, M., and Stasio\u0142ek, M. (2023). Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020425"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1212\/NXI.0000000000000815","article-title":"CSF Chitinase 3-like-1 Association with Disability of Primary Progressive MS","volume":"7","author":"Prefasi","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"102697","DOI":"10.1016\/j.msard.2020.102697","article-title":"CSF Levels of HoxB3 and YKL-40 May Predict Conversion from Clinically Isolated Syndrome to Relapsing Remitting Multiple Sclerosis","volume":"48","author":"Tamam","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1515\/revneuro-2020-0145","article-title":"Neuronal and Glial CSF Biomarkers in Multiple Sclerosis: A Systematic Review and Meta-Analysis","volume":"32","author":"Momtazmanesh","year":"2021","journal-title":"Rev. Neurosci."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Ruder, J., Dinner, G., Maceski, A., Berenjeno-Correa, E., M\u00fcller, A.M., Jelcic, I., Kuhle, J., and Martin, R. (2022). Dynamics of Inflammatory and Neurodegenerative Biomarkers after Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810946"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Oset, M., Domowicz, M., Wildner, P., Siger, M., Karli\u0144ska, I., Stasio\u0142ek, M., and \u015awiderek-Matysiak, M. (2023). Predictive Value of Brain Atrophy, Serum Biomarkers and Information Processing Speed for Early Disease Progression in Multiple Sclerosis. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1223220"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cca.2011.01.022","article-title":"Plasma YKL-40 Levels in Healthy Subjects from the General Population","volume":"412","author":"Bojesen","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/rheumatology\/38.7.618","article-title":"Serum YKL-40 Concentrations in Patients with Rheumatoid Arthritis: Relation to Disease Activity","volume":"38","author":"Johansen","year":"1999","journal-title":"Rheumatology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/cancers2031453","article-title":"YKL-40\u2014A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?","volume":"2","author":"Schultz","year":"2010","journal-title":"Cancers"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Modvig, S., Degn, M., Horwitz, H., Cramer, S.P., Larsson, H.B.W., Wanscher, B., Sellebjerg, F., and Frederiksen, J.L. (2013). Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077163"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum Neurofilament Light Levels in Normal Aging and Their Association with Morphologic Brain Changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"V\u00e5gberg, M., Norgren, N., Dring, A., Lindqvist, T., Birgander, R., Zetterberg, H., and Svenningsson, A. (2015). Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135886"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/acn3.51524","article-title":"Development of an Age-Adjusted Model for Blood Neurofilament Light Chain","volume":"9","author":"Harp","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/jnnp.64.3.402","article-title":"Neurofilament Protein in Cerebrospinal Fluid: A Potential Marker of Activity in Multiple Sclerosis","volume":"64","author":"Lycke","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/01.WNL.0000098880.19793.B6","article-title":"Neurofilament Light Protein and Glial Fibrillary Acidic Protein as Biological Markers in MS","volume":"61","author":"Haghighi","year":"2003","journal-title":"Neurology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-0270(94)90011-6","article-title":"A Sensitive ELISA for Glial Fibrillary Acidic Protein: Application in CSF of Adults","volume":"51","author":"Rosengren","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.imbio.2015.09.023","article-title":"CHI3L1 Nuclear Localization in Monocyte Derived Dendritic Cells","volume":"221","author":"Tibullo","year":"2016","journal-title":"Immunobiology"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Jatczak-Pawlik, I., Ewiak-Paszy\u0144ska, A., Domowicz, M., Jurewicz, A., and Stasio\u0142ek, M. (2024). Intracellular Accumulation and Secretion of YKL-40 (CHI3L1) in the Course of DMSO-Induced HL-60 Cell Differentiation. Pharmaceuticals, 17.","DOI":"10.3390\/ph17040443"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41467-017-02731-6","article-title":"Regulation of Chitinase-3-like-1 in T Cell Elicits Th1 and Cytotoxic Responses to Inhibit Lung Metastasis","volume":"9","author":"Kim","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-017-0408-0","article-title":"Tumor-Recruited M2 Macrophages Promote Gastric and Breast Cancer Metastasis via M2 Macrophage-Secreted CHI3L1 Protein","volume":"10","author":"Chen","year":"2017","journal-title":"J. Hematol. Oncol"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"107394","DOI":"10.1016\/j.pharmthera.2019.107394","article-title":"Roles of Chitinase 3-like 1 in the Development of Cancer, Neurodegenerative Diseases, and Inflammatory Diseases","volume":"203","author":"Yeo","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41467-018-08140-7","article-title":"Chi3l3 Induces Oligodendrogenesis in an Experimental Model of Autoimmune Neuroinflammation","volume":"10","author":"Starossom","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/NEN.0b013e31826eaee7","article-title":"Exacerbation of Experimental Autoimmune Encephalomyelitis in the Absence of Breast Regression Protein-39\/Chitinase 3-like-1","volume":"71","author":"Wang","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2015.06.004","article-title":"Breast Regression Protein-39 Is Not Required for Experimental Autoimmune Encephalomyelitis Induction","volume":"160","author":"Espejo","year":"2015","journal-title":"Clin. Immunol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/24\/2086\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:54:01Z","timestamp":1760115241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/24\/2086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":149,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["cells13242086"],"URL":"https:\/\/doi.org\/10.3390\/cells13242086","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}